Mytrus appoints Anthony Costello as CEO

Friday, July 6, 2012 01:33 PM

Mytrus, a San Francisco-based clinical technology and services company for medical and pharmaceutical research, has appointed Anthony J. Costello as CEO. He

Costello is one of the founding members of Mytrus and previously served as its COO.  Before joining the company in 2009, he co-founded Nextrials and served as its vice president of product development. Costello also served for several years as manager of oncology clinical data management at Genentech. He is a past chairman of the board of trustees for the Society of Clinical Data Management and a member of the editorial advisory board for Applied Clinical Trials magazine.

Steve Cummings, the former Mytrus CEO, now serves as the company’s new CSO and remains as chairman of the board of directors.

Share:          
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs